Is SKIN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.

SKIN (SkinHealth Systems Inc. Class A Common Stock) Stock Analysis - Financials

SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of November 5, 2026, SKIN trades at $10.31 with a market cap of $71.99M and a P/E ratio of -7.78. SKIN moved -6.74% today. Year to date, SKIN is -63.09%; over the trailing twelve months it is -64.59%. Its 52-week range spans $9.68 to $53.80. Analyst consensus is neutral with an average price target of $12.50. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SKIN's key financials?

SKIN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SKIN recently traded at $10.31. Market cap is $71.99M. P/E ratio is -7.78. Revenue is $300.79M.

SKIN Key Metrics

Key financial metrics for SKIN
Metric	Value
Price	$10.31
Market Cap	$71.99M
P/E Ratio	-7.78
EPS	$-0.08
Dividend Yield	0.00%
52-Week High	$53.80
52-Week Low	$9.68
Volume	22.25K
Avg Volume	0
Revenue (TTM)	$300.79M
Net Income	$-9.52M
Gross Margin	65.28%

SKIN Analyst Consensus

4 analysts cover SKIN: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.50.

Common questions about SKIN

What are SKIN's key financials?: SKIN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SKIN recently traded at $10.31. Market cap is $71.99M. P/E ratio is -7.78. Revenue is $300.79M.
Is SKIN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.